yingweiwo

New1

New1

New1 related products

Structure Cat No. Product Name CAS No. Product Description
KB-141 V23153 KB-141 219691-94-8 KB-141 is a potent and specific TRβ agonist.
KB-74935 V23154 KB-74935 946398-78-3 KB-74935 is a novel and potent bioactive compound
KBG 4 V23155 KBG 4 63811-80-3 KBG 4 is a novel and potent bioactive compound
KBH-A42 V20596 KBH-A42 798543-50-7 KBH-A42 is a novel and potent histone deacetylase inhibitor
KBP-7018 V23156 KBP-7018 1613437-66-3 KBP-7018 is a selective inhibitor of tyrosine kinases.
KBP-7018 HCl V23157 KBP-7018 HCl 1613437-67-4 KBP-7018 HCl is a novel and potent tyrosine kinase inhibitor
KBR 2822 V23158 KBR 2822 126988-60-1 KBR 2822 is a novel and potent esterase inhibitor
KBU2046 V23159 KBU2046 1143863-69-7 KBU2046 is an orally bioactive, selective inhibitor of cell motility and invasion in vitro.
KC 400 V23160 KC 400 12737-87-0 KC 400 is a novel and potent mixture of polychlorinated biphenyls
KC-11 V27848 KC-11 KC-11 is a novel and potent inhibitor of mtb-dhfr
KC-12615 V23163 KC-12615 182821-29-0 KC-12615 is a novel and potent endopeptidase inhibitior
KC01 V23161 KC01 1646795-59-6 KC01 is a potent inhibitor of ABHD16A, with IC50 of 90 nM for hABHD16A and IC50 of 520 nM for mABHD16A; KC01 significantly reduces lyso-PSs, thereby reducing lyso-PS and lipopolysaccharide-induced cell death in mouse macrophages.
KCA-1490 V23164 KCA-1490 909719-71-7 KCA-1490 is a novel and potent PDE3/4 inhibitor
KCC009 V6433 KCC009 744198-19-4 KCC009 is a novel, potent and selective inhibitor of Transglutaminase 2, it is able to disrupt fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.
KCG 1 V23166 KCG 1 139036-51-4 KCG 1 is a novel and potent keto-C-glycoside drug
KCN1 V23167 KCN1 927823-01-6 KCN1 is a novel and potent HIF pathway inhibitor
KCO-912 V23168 KCO-912 185695-83-4 KCO-912 is a novel and potent ATP-dependent K channel opener
KD-026 V21896 KD-026 913541-47-6 SLX-4090, an orally bioactive, enterocyte-specific microsomal triglyceride transfer protein (MTP) inhibitor (antagonist) with IC50 of 8.0 nM.
KD-027 V18974 KD-027 906421-01-0 KD-027 (SLx-2101;KD 027; SLx 2101;KD027; SLx2101) is a novel and potent PDE5A inhibitor with potential anti-hypertensive activity.
KDM4-IN-I V23171 KDM4-IN-I 23705-85-3 KDM4-IN-I is a novel and potent KDM4 inhibitor
Contact Us